Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Steinberg

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biomedical Journal of Scientific & Technical Research|October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid CrisisKenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Journal of Systems and Integrative Neuroscience|September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemicKenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Journal of Reward Deficiency Syndrome and Addiction Science|July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Current Psychopharmacology|May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk TestingKenneth Blum, David Baron, Lisa Lott, et al.
Current Psychopharmacology|October 28, 2021
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain DevelopmentKenneth Blum, Abdalla Bowirrat, Marjorie C Gondre Lewis, et al.
Frontiers in Bioscience (Elite Edition)|September 21, 2017
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependenceKenneth Blum, Amanda L C Chen, Panayotis K Thanos, et al.
International Journal of Genomics and Data Mining|September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARSKenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biomedical Journal of Scientific & Technical Research|October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid CrisisKenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Journal of Systems and Integrative Neuroscience|September 11, 2018
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemicKenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, et al.
Journal of Reward Deficiency Syndrome and Addiction Science|July 3, 2018
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Current Psychopharmacology|May 21, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk TestingKenneth Blum, David Baron, Lisa Lott, et al.
Current Psychopharmacology|October 28, 2021
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain DevelopmentKenneth Blum, Abdalla Bowirrat, Marjorie C Gondre Lewis, et al.
Frontiers in Bioscience (Elite Edition)|September 21, 2017
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependenceKenneth Blum, Amanda L C Chen, Panayotis K Thanos, et al.
International Journal of Genomics and Data Mining|September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARSKenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Pageof 3